[PDF] Top 20 Revisão da educação e tecnologia de um olhar pedagógico
Has 10000 "Revisão da educação e tecnologia de um olhar pedagógico" found on our website. Below are the top 20 most common "Revisão da educação e tecnologia de um olhar pedagógico".
Haemophilus influenzae Type b Conjugate Vaccine
... Berkowitz CD, Ward JI, Hendley JO, et al: Persistence of antibody (ab) to Haemophilus influenzae type b (Hib) and response to PRP and PRP-D booster immunization in chil- dren initially i[r] ... See full document
10
Opsonophagocidal Activity in Sera From Infants and Children Immunized With Haemophilus influenzae Type b Conjugate Vaccine (Meningococcal Protein Conjugate)
... seria meningitidis group B.’2 The latter approach has yielded a vaccine that elicits a good antibody response after a single 15-ag dose of vaccine in infants as young as 2 months of age,[r] ... See full document
5
Haemophilus influenzae Type b Conjugate Vaccine (Meningococcal Protein Conjugate) (PedvaxHIBTM): Clinical Evaluation
... Haemophilus b conjugate vaccine (meningococcal protein conjugate), PedvaxHlBa (PRP-OMPC), is a con- jugate H influenzae type b vaccine developed at Merck Sharp & Dohme Research Labor[r] ... See full document
5
Clinical Experience With Haemophilus influenzae Type b Conjugate Vaccines
... Three conjugate vaccines have been tested for immunogenicity in infants in Finland: PRP-D, a conjugate of PRP with diphtheria toxoi&2; HbOC, a conjugate of PRP-derived oligosaccharid[r] ... See full document
31
Effectiveness and Safety of an Haemophilus influenzae Type b Conjugate Vaccine (PRP-T) in Young Infants
... The rates of systemic and local reactions occurring within 72 hours of each vaccine dose were generally similar for infants given PRP-T and hepatitis B, but some reaction rates (local re[r] ... See full document
6
Immunogenicity of a New Haemophilus influenzae Type b Conjugate Vaccine (Meningococcal Protein Conjugate) (PedvaxHIBTM)
... when challenged with a virulent H influenzae type b strain isolated from a human clinical case of H influenzae type b meningitis (Table 7); the histo- pathology observed in rats is simil[r] ... See full document
25
Haemophilus influenzae Type b Conjugate Vaccine (Meningicoccal Protein Conjugate): Immunogenicity and Safety at Various Doses
... effect of dose of PRP-OMPC on anti-PRP antibody levels in children and infants as young as 2 months of age.. In addition, the safety of PRP-OMPC at different doses was.[r] ... See full document
14
Epiglottitis and Haemophilus influenzae Immunization: The Pittsburgh Experience–A Five-Year Review
... Haemophilus influenzae type b polysaccharide and conjugate vaccines in children 18 months of age and older. Wenger JD, Pierce R, Deaver KA, et al[r] ... See full document
10
The impact of Hib conjugate vaccine on the epidemiology of invasive Haemophilus influenzae disease in the West Midlands and the effect of deprivation and other environmental risk factors : an ecological study, 1990 1994
... The impact of Hib conjugate vaccine on the invasive Haemophilus influenzae of epidemiology disease in the West Midlands and the effect of deprivation and other environmental risk factors[r] ... See full document
40
Anti-Polyribosylribitol Phosphate Antibody Concentrations and Avidities in Children since the Start of Haemophilus influenzae Type b Immunization of Infants in the United Kingdom
... Hib conjugate vaccine at 2, 3, and 4 months, and in the absence of further boosting, an initial peak anti-PRP antibody level declines quickly over the following months ...Hib vaccine seen within the ... See full document
78
Time to Tackle the Tough Issues in Patient Safety
... S ince at least the turn of the 20th century, the value of milk as a nutrient-dense food for chil- dren has been reflected in documents that call for its inclusion in public feeding programs (Table 1). In 1909, children ... See full document
5
AMERICAN ACADEMY OF PEDIATRICS Combination Vaccines for Childhood Immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP), the American Academy of Pediatrics (AAP), and the American Academy of Family Physicians (AAFP)*
... OF VACCINE PRODUCTS In general, vaccines from different manufacturers that protect against the same disease may be admin- istered interchangeably in sequential doses in the immunization series for an individual ... See full document
7
Haemophilus influenzae Type b Vaccine: Use in the Pediatric Population
... The survey instrument was designed to obtain information regarding type of practice, average monthly patient census, provider familiarity with the Immunizations Practices Advisory Commit[r] ... See full document
6
Safety and Immunogenicity of Haemophilus influenzae Type b Oligosaccharide-CRM197 Conjugate Vaccine in Infants Aged 15 to 23 Months
... One month after a single vaccination, the anti-H influenzae type b capsular polysaccharide antibody concentration rose from a geo- metric mean prevaccination level of 0.20 sg/mL to 13.77[r] ... See full document
20
Safety and Immunogenicity of Haemophilus influenzae Type b Oligosaccharide-CRM197 Conjugate Vaccine in Infants Aged 15 to 23 Months
... cine is superior.28 The anti-HbPs response gener- ated by one 10-ag dose of HbOC evaluated 1 month after vaccination was greater than the response measured 1 month postvaccination of 22-[r] ... See full document
16
Immunogenicity of Haemophilus influenzae Type b Polysaccharide-Protein Conjugate Vaccines in Children With Conditions Associated With Impaired Antibody Responses to Type b Polysaccharide Vaccine
... IgG subclass composition of the antibody response ofhealthy adults, and normal or IgG2- deficient children to immunization with H influenzae type b polysaccharide vaccine or Hib PS-prote[r] ... See full document
5
Case report of congenital asplenia presenting with Haemophilus influenzae type a (Hia) sepsis: an emerging pediatric infection in Minnesota
... A five-year-old, fully vaccinated, American Indian female presented to a rural community hospital in Minnesota with a 4-day history of vomiting and diarrhea, followed by the development of fevers and progressive ... See full document
9
Safety and Efficacy of Haemophilus influenzae Type b Polysaccharide Vaccine
... Estimated Number of Cases of Haemophilus Disease Prevented or Associated With Vaccination in a Cohort of 68,200 Minnesota Children 24 to 35 Months of. Age[r] ... See full document
9
Haemophilus influenzae Type b Polysaccharide-Diphtheria Toxoid Conjugate Vaccine in Vaccinated Children Who Developed Haemophilus Disease
... Of the 14 children who had vaccine failure, 3 had <1 zg/mL of anticapsular antibody after immuni- zation with PRP-diphtheria; 1 of the 3 children had familial C2 (complement) deficien[r] ... See full document
6
Haemophilus influenzae Type b Polysaccharide Vaccine: An Efficacy Study
... The finding of parental smoking as a risk factor for primary H influenzae type b disease (matched odds ratio = 2.37; 95% confidence interval = 1.17%,.. 4.82%) is difficult to interpret, [r] ... See full document
7
Related subjects